Global Cell and Gene Therapy Solutions Market Research Report 2025

Publication ID:

PB502256029

Publication Date:

February 13, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Cell and Gene Therapy Solutions was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cell & gene therapies are used to treat both rare and common diseases. While gene therapy involves the transfer of genetic material, usually within a virus for uptake into diseased cells, cell therapy involves the transfer of genetically altered cells into a patient.
The field of cell and gene therapy is currently in a phase of robust growth, with an expanding market size. As scientific advancements continue, the application scope of cell and gene therapies is widening, encompassing the treatment of various diseases such as cancer, genetic disorders, and autoimmune conditions. Sales within this sector are on a consistent upward trajectory, reflecting significant commercial potential. While some remarkable successes have been achieved in the realm of cell and gene therapy, challenges concerning safety and regulatory compliance persist. Looking ahead, as research deepens, it is anticipated that the field will continue to make breakthroughs, ushering in more innovation and transformative changes within the medical domain.
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Solutions.
The Cell and Gene Therapy Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell and Gene Therapy Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bluebird Bio
Sarepta Therapeutics
Solid Biosciences
Novartis
Biomarin Pharmaceutical
Uniqure
Spark Therapeutics
Alaunos Therapeutics
Homology Medicines
Biogen
Legend Biotech
CARsgen
Segment by Type
Stem Cell Therapy
Gene Therapy
Other
Segment by Application
Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell and Gene Therapy Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Solutions Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cell Therapy
1.2.3 Gene Therapy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Solutions Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Solutions Market Perspective (2020-2031)
2.2 Global Cell and Gene Therapy Solutions Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Solutions Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell and Gene Therapy Solutions Historic Market Size by Region (2020-2025)
2.2.3 Cell and Gene Therapy Solutions Forecasted Market Size by Region (2026-2031)
2.3 Cell and Gene Therapy Solutions Market Dynamics
2.3.1 Cell and Gene Therapy Solutions Industry Trends
2.3.2 Cell and Gene Therapy Solutions Market Drivers
2.3.3 Cell and Gene Therapy Solutions Market Challenges
2.3.4 Cell and Gene Therapy Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Solutions Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Solutions Players by Revenue (2020-2025)
3.1.2 Global Cell and Gene Therapy Solutions Revenue Market Share by Players (2020-2025)
3.2 Global Cell and Gene Therapy Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy Solutions Revenue
3.4 Global Cell and Gene Therapy Solutions Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Solutions Revenue in 2024
3.5 Global Key Players of Cell and Gene Therapy Solutions Head office and Area Served
3.6 Global Key Players of Cell and Gene Therapy Solutions, Product and Application
3.7 Global Key Players of Cell and Gene Therapy Solutions, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Solutions Breakdown Data by Type
4.1 Global Cell and Gene Therapy Solutions Historic Market Size by Type (2020-2025)
4.2 Global Cell and Gene Therapy Solutions Forecasted Market Size by Type (2026-2031)
5 Cell and Gene Therapy Solutions Breakdown Data by Application
5.1 Global Cell and Gene Therapy Solutions Historic Market Size by Application (2020-2025)
5.2 Global Cell and Gene Therapy Solutions Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell and Gene Therapy Solutions Market Size (2020-2031)
6.2 North America Cell and Gene Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell and Gene Therapy Solutions Market Size by Country (2020-2025)
6.4 North America Cell and Gene Therapy Solutions Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Solutions Market Size (2020-2031)
7.2 Europe Cell and Gene Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell and Gene Therapy Solutions Market Size by Country (2020-2025)
7.4 Europe Cell and Gene Therapy Solutions Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Solutions Market Size (2020-2031)
8.2 Asia-Pacific Cell and Gene Therapy Solutions Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell and Gene Therapy Solutions Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell and Gene Therapy Solutions Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Solutions Market Size (2020-2031)
9.2 Latin America Cell and Gene Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell and Gene Therapy Solutions Market Size by Country (2020-2025)
9.4 Latin America Cell and Gene Therapy Solutions Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Solutions Market Size (2020-2031)
10.2 Middle East & Africa Cell and Gene Therapy Solutions Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell and Gene Therapy Solutions Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell and Gene Therapy Solutions Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Details
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Cell and Gene Therapy Solutions Introduction
11.1.4 Bluebird Bio Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.1.5 Bluebird Bio Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Details
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Cell and Gene Therapy Solutions Introduction
11.2.4 Sarepta Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Solid Biosciences
11.3.1 Solid Biosciences Company Details
11.3.2 Solid Biosciences Business Overview
11.3.3 Solid Biosciences Cell and Gene Therapy Solutions Introduction
11.3.4 Solid Biosciences Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.3.5 Solid Biosciences Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cell and Gene Therapy Solutions Introduction
11.4.4 Novartis Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Biomarin Pharmaceutical
11.5.1 Biomarin Pharmaceutical Company Details
11.5.2 Biomarin Pharmaceutical Business Overview
11.5.3 Biomarin Pharmaceutical Cell and Gene Therapy Solutions Introduction
11.5.4 Biomarin Pharmaceutical Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.5.5 Biomarin Pharmaceutical Recent Development
11.6 Uniqure
11.6.1 Uniqure Company Details
11.6.2 Uniqure Business Overview
11.6.3 Uniqure Cell and Gene Therapy Solutions Introduction
11.6.4 Uniqure Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.6.5 Uniqure Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Cell and Gene Therapy Solutions Introduction
11.7.4 Spark Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.7.5 Spark Therapeutics Recent Development
11.8 Alaunos Therapeutics
11.8.1 Alaunos Therapeutics Company Details
11.8.2 Alaunos Therapeutics Business Overview
11.8.3 Alaunos Therapeutics Cell and Gene Therapy Solutions Introduction
11.8.4 Alaunos Therapeutics Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.8.5 Alaunos Therapeutics Recent Development
11.9 Homology Medicines
11.9.1 Homology Medicines Company Details
11.9.2 Homology Medicines Business Overview
11.9.3 Homology Medicines Cell and Gene Therapy Solutions Introduction
11.9.4 Homology Medicines Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.9.5 Homology Medicines Recent Development
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Cell and Gene Therapy Solutions Introduction
11.10.4 Biogen Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.10.5 Biogen Recent Development
11.11 Legend Biotech
11.11.1 Legend Biotech Company Details
11.11.2 Legend Biotech Business Overview
11.11.3 Legend Biotech Cell and Gene Therapy Solutions Introduction
11.11.4 Legend Biotech Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.11.5 Legend Biotech Recent Development
11.12 CARsgen
11.12.1 CARsgen Company Details
11.12.2 CARsgen Business Overview
11.12.3 CARsgen Cell and Gene Therapy Solutions Introduction
11.12.4 CARsgen Revenue in Cell and Gene Therapy Solutions Business (2020-2025)
11.12.5 CARsgen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Bluebird Bio
Sarepta Therapeutics
Solid Biosciences
Novartis
Biomarin Pharmaceutical
Uniqure
Spark Therapeutics
Alaunos Therapeutics
Homology Medicines
Biogen
Legend Biotech
CARsgen

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂